awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q35005762-4BC2A0E7-7782-4D9A-A301-652A4F650FB7
Q35005762-4BC2A0E7-7782-4D9A-A301-652A4F650FB7
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35005762-4BC2A0E7-7782-4D9A-A301-652A4F650FB7
Neoadjuvant treatment with docetaxel plus lapatinib, trastuzumab, or both followed by an anthracycline-based chemotherapy in HER2-positive breast cancer: results of the randomised phase II EORTC 10054 study.
P2860
Q35005762-4BC2A0E7-7782-4D9A-A301-652A4F650FB7
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35005762-4BC2A0E7-7782-4D9A-A301-652A4F650FB7
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
4df82a8198694f1be119a977c51f8396b672f2cc
P2860
A phase II study of lapatinib monotherapy in chemotherapy-refractory HER2-positive and HER2-negative advanced or metastatic breast cancer.